🇺🇸 FDA
Patent

US 8318425

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein

granted A61KA61K31/56A61K45/06

Quick answer

US patent 8318425 (Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein) held by The United States of America, as Represented by the Secretary, Department of Human Services expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as Represented by the Secretary, Department of Human Services
Grant date
Tue Nov 27 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K31/56, A61K45/06, A61P, A61P31/12